Patent · US Active

CDK inhibitors

US8691830B2 · kind B2 · utility

42Cited by
0References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2013
Grant dateApr 8, 2014
Priority date—
Expiry dateApr 24, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.